A ‘brain training’ game developed by researchers at the University of Cambridge could help improve the memory of patients in the very earliest stages of dementia, suggests a study published today in The International Journal of Neuropsychopharmacology.
Opinion: Brain scanners allow scientists to ‘read minds’ – could they now enable a ‘Big Brother’ future?13 Feb 2017
Brain imaging can reveal a great deal about who we are and what is going inside our heads. But how far can – and should – this research take us? Julia Gottwald and Barbara Sahakian, authors of Sex, Lies, and Brain Scans: How fMRI Reveals What Really Goes on in our Minds, investigate for The Conversation.
Modafinil, a drug used to treat narcolepsy – excessive daytime sleepiness – can improve memory in patients recovering from depression, according to new research from the University of Cambridge. The findings, published today in the journal Biological Psychiatry: CNNI, result from a randomised, double-blind, placebo-controlled study and offer hope of a treatment for some of the cognitive symptoms of depression.
Rapid advances in neuroscience are driving a huge shift in our understanding of how the brain works and could improve both our cognitive abilities and our brain health, writes Professor Barbara Sahakian (Department of Psychiatry) on The Conversation website.
Barbara Sahakian (Department of Psychiatry) discusses 'smart drugs' and other ways to boost our cognitive abilities.
A ‘brain training’ iPad game developed and tested by researchers at the University of Cambridge may improve the memory of patients with schizophrenia, helping them in their daily lives at work and living independently, according to research published today.
Misfiring of the brain’s control system might underpin compulsions in obsessive-compulsive disorder (OCD), according to researchers at the University of Cambridge, writing in the American Journal of Psychiatry.
Last month, the Medicines and Healthcare products Regulatory Agency announced the UK’s biggest ever single seizure of smart drugs, also known as cognitive enhancers. With over 20,000 units, of 13 different types of cognitive enhancement medicines, the seizure represents an approximate value of £200,000. Here, Professor Barbara Sahakian from the Department of Psychiatry discusses the implications. This article first appeared on The Conversation website on 31 October 2014.
A US Congressional delegation on ageing and dementia policy visited the University of Cambridge this week to hear about UK research into one of the biggest healthcare challenges facing both the UK and US.
Traumatic brain injury affects 10 million people a year worldwide and is the leading cause of death and disability in children and young adults. A new study will identify how to match treatments to patients, to achieve the best possible outcome for recovery.